With pillars in “Big DNA” assembly and delivery, cellular reprogramming, and protein redesign, Adrian Woolfson and Lachlan Mackinnon have teamed up to rewrite the blueprint for biotechnology companies . . .
Replay Launches with $55 Million Seed to Transform Genomic Medicine with Interlinking Technology Platforms
With pillars in “Big DNA” assembly and delivery, cellular reprogramming, and protein redesign, Adrian Woolfson and Lachlan Mackinnon have teamed up to rewrite the blueprint for biotechnology companies.
[iStock / Getty Images Plus]
